Urolog. pro Praxi, 2007; 1: 10-14

OBESITY, ADIPOCYTOKINES, AND PROSTATE CANCER

MUDr. Daniel Housa1, doc. MUDr. Martin Haluzík CSc2, MUDr. Zdena Vernerová CSc1, MUDr. Jitka Housová Ph.D2, MUDr. Jiří Heráček3
1 Ústav patologie 3. LF UK a FN KV Praha
2 III. interní klinika VFN a 1. LF UK, Praha
3 Urologická klinika 3. LF UK a FN KV v Praze

Obesity and adipose-tissue derived hormones (adipocytokines) are known to play an important role in the development of several types of malignancies including prostate cancer. We summarize the current knowledge of the possible relationship of obesity, leptin, and adiponectin in the process of prostate cancer development and progression.

Keywords: obesity, adipocytokines, leptin, adiponectin

Published: January 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Housa D, Haluzík M, Vernerová Z, Housová J, Heráček J. OBESITY, ADIPOCYTOKINES, AND PROSTATE CANCER. Urol. praxi. 2007;8(1):10-14.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Amling CL. Relationship between obesity and prostate cancer. Curr Opin Urol 2005; 3 (15): 167-171. Go to original source... Go to PubMed...
    2. Amling CL, Riffenburgh RH, Sun L et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004; 3 (22): 439-445. Go to original source... Go to PubMed...
    3. Anderson SO, Wolk A, Bergstrom R et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 1997; 5 (89): 385-389. Go to original source... Go to PubMed...
    4. Aziz N, Hartman T, Barrett M et al. Weight and prostate cancer in the Alpha-Tocopherol. BetaCarotene Cancer Prevention (ATBC) Trial [Abstract]. ASCO 2000; 19.
    5. Baillargeon J, Platz EA, Rose DP et al. Obesity, adipokines, and prostate cancer in a prospective population-based study. Cancer Epidemiol Biomarkers Prev 2006; 7 (15): 1331-1335. Go to original source... Go to PubMed...
    6. Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 17 (348): 1625-1638. Go to original source... Go to PubMed...
    7. Engeland A, Tretli S, Bjorge T. Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer 2003; 7 (89): 1237-1242. Go to original source... Go to PubMed...
    8. Freedland SJ, Aronson WJ, Kane CJ et al. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 2004; 3 (22): 446-453. Go to original source... Go to PubMed...
    9. Freedland SJ, Sokoll LJ, Mangold LA et al. Serum leptin and pathological findings at the time of radical prostatectomy. J Urol 2005; 3 (173): 773-776. Go to original source... Go to PubMed...
    10. Freedland SJ, Sokoll LJ, Platz EA et al. Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy. J Urol 2005; 4 (174): 1266-1270. Go to original source... Go to PubMed...
    11. Giovannucci E, Rimm EB, Liu Y et al. Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 2003; 16 (95): 1240-1244. Go to original source... Go to PubMed...
    12. Goktas S, Yilmaz MI, Caglar K et al. Prostate cancer and adiponectin. Urology 2005; 6 (65): 1168-1172. Go to original source... Go to PubMed...
    13. Housa D, Housova J, Vernerova Z et al. Adipocytokines and cancer. Physiol Res 2006; 3 (55): 233-244. Go to original source...
    14. Hsing AW, Deng J, Sesterhenn IA et al. Body size and prostate cancer: a population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 2000; 12 (9): 1335-1341.
    15. Chang S, Hursting SD, Contois JH et al. Leptin and prostate cancer. Prostate 2001; 1 (46): 62-67. Go to original source...
    16. Presti JC Jr, Lee U, Brooks JD et al. Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population. J Urol 2004; 6 (171): 2199-2202. Go to original source... Go to PubMed...
    17. Rodriguez C, Patel AV, Calle EE et al. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 2001; 4 (10): 345-353.
    18. Schuurman AG, Goldbohm RA, Dorant E et al. Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 2000; 6 (151): 541-549. Go to original source... Go to PubMed...
    19. Snowdon DA, Phillips RL, Choi W. Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol 1984; 2 (120): 244-250. Go to original source... Go to PubMed...
    20. Thompson IM, Leach R, Troyer D et al. Relationship of body mass index and prostate specific antigen in a population-based study. Urol Oncol 2004; 2 (22): 127-131. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.